Applied Photophysics appoints Louise Madden as CEO

1-Feb-2017

Sue Cresswell also joins as Marketing Manager and Koos van der Steuijt as Global Sales Director


With over a decade of experience within the analytical instruments field, Louise Madden joined Applied Photophysics in March 2014 as commercial director, before being promoted to Chief Operating Officer in 2015. She has a BA in Law and Accountancy from the University of Manchester.

Madden was previously Finance Director at Farfield Group Limited and Global Service Manager at Biolin Scientific AB.

She spent 11 years at KPMG, where her clients ranged from owner-managed businesses to multinational PLCs.

The company has also appointed Sue Cresswell as Marketing Manager. Cresswell has introduced new companies and technologies to the global life science market and driven the transition of biotech supply companies from a technological- to a commercially-focused approach.

She has established two successful market communications agencies and was previously Market Communications Director at Biacore SA (now GE Healthcare).

Koos van der Steuijt will also become Global Sales Director.

With significant experience of growing sales in the life science sector, Steuijt joins from VWR Singapore Pte Ltd, where he was Vice President, General Manager Singapore and China. In this role, he was responsible for P&L in China and Singapore.

Previously he held several senior management roles at Thermo Fisher Scientific, including Vice President, General Manager Korea, Vice President, General Manager India and Commercial European Business Unit Director Molecular/Surface Analysis.

Applied Photophysics is a provider of systems and accessories for the biophysical characterisation of biomolecules.

Using circular dichroism (CD), the company’s Chirascan systems enable scientists to discover and determine the significance of changes in the higher order structure (HOS) and stability of proteins.

Chirascan systems help to maintain momentum during the development of innovator drugs and biosimilars in the biopharmaceutical industry. The company’s range of stopped-flow spectrometers are acknowledged globally as the gold standard for kinetic studies of fast biological reactions.

Sign up for your free email newsletter

Companies